Abstract
Hypertension among patients on peritoneal dialysis (PD) is highly prevalent and remains often inadequately controlled. The burden and epidemiology of hypertension in this dialytic modality appear to follow similar patterns akin to in-center hemodialysis. Once an accurate diagnosis is made with the use of home or ambulatory blood pressure (BP) monitoring, management of hypertension relies firstly on non-pharmacological strategies aiming to control sodium and volume overload. Dietary sodium restriction, individualized prescription of the PD regimen according to the peritoneal transport characteristics, and appropriate use of icodextrin solutions during the long dwells are effective therapeutic approaches that facilitate the achievement of dry-weight. When BP is not adequately controlled with non-pharmacological management, antihypertensive drug therapy then becomes necessary. Choice of the appropriate antihypertensive agent should be individualized and should take into consideration the presence of comorbidities and other clinical characteristics of each patient. β-Blockers are our preferred antihypertensive drug class in pharmacotherapy of hypertension in patients on dialysis. Long-acting dihydropyridine calcium-channel-blockers and agents blocking the renin-angiotensin-system are our second- and third-line choices. In this chapter, we discuss the epidemiology, diagnosis, and management of hypertension among patients on PD. We provide a comparative evaluation between PD and in-center hemodialysis and conclude with clinical practice recommendations and a call for randomized trials to elucidate several areas of uncertainty in the management of hypertension in this high-risk population.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Georgianos PI, Agarwal R. Epidemiology, diagnosis and management of hypertension among patients on chronic dialysis. Nat Rev Nephrol. 2016;12(10):636–47.
Rocco MV, Flanigan MJ, Beaver S, et al. Report from the 1995 Core Indicators for Peritoneal Dialysis Study Group. Am J Kidney Dis. 1997;30(2):165–73.
Agarwal R, Nissenson AR, Batlle D, Coyne DW, Trout JR, Warnock DG. Prevalence, treatment, and control of hypertension in chronic hemodialysis patients in the United States. Am J Med. 2003;115(4):291–7.
Cocchi R, Degli EE, Fabbri A, et al. Prevalence of hypertension in patients on peritoneal dialysis: results of an Italian Multicentre Study. Nephrol Dial Transplant. 1999;14(6):1536–40.
Agarwal R, Light RP. Arterial stiffness and interdialytic weight gain influence ambulatory blood pressure patterns in hemodialysis patients. Am J Physiol Renal Physiol. 2008;294(2):F303–8.
Rodby RA, Vonesh EF, Korbet SM. Blood pressures in hemodialysis and peritoneal dialysis using ambulatory blood pressure monitoring. Am J Kidney Dis. 1994;23(3):401–11.
Tonbul Z, Altintepe L, Sozlu C, Yeksan M, Yildiz A, Turk S. Ambulatory blood pressure monitoring in haemodialysis and continuous ambulatory peritoneal dialysis (CAPD) patients. J Hum Hypertens. 2002;16(8):585–9.
Georgianos PI, Agarwal R. Blood pressure and mortality in long-term hemodialysis-time to move forward. Am J Hypertens. 2017;30(3):211–22.
Kalantar-Zadeh K, Kilpatrick RD, Mcallister CJ, Greenland S, Kopple JD. Reverse epidemiology of hypertension and cardiovascular death in the hemodialysis population: the 58th annual fall conference and scientific sessions. Hypertension. 2005;45(4):811–7.
Zager PG, Nikolic J, Brown RH, et al. “U” Curve Association of blood pressure and mortality in hemodialysis patients. Medical Directors Of Dialysis Clinic, Inc. Kidney Int. 1998;54(2):561–9.
Afshinnia F, Zaky ZS, Metireddy M, Segal JH. Reverse epidemiology of blood pressure in peritoneal dialysis associated with dynamic deterioration of left ventricular function. Perit Dial Int. 2016;36(2):154–62.
Goldfarb-Rumyantzev AS, Baird BC, Leypoldt JK, Cheung AK. The association between BP and mortality in patients on chronic peritoneal dialysis. Nephrol Dial Transplant. 2005;20(8):1693–701.
Udayaraj UP, Steenkamp R, Caskey FJ, et al. Blood pressure and mortality risk on peritoneal dialysis. Am J Kidney Dis. 2009;53(1):70–8.
Agarwal R. Blood pressure and mortality among hemodialysis patients. Hypertension. 2010;55(3):762–8.
Alborzi P, Patel N, Agarwal R. Home blood pressures are of greater prognostic value than hemodialysis unit recordings. Clin J Am Soc Nephrol. 2007;2(6):1228–34.
Bansal N, Mcculloch CE, Rahman M, et al. Blood pressure and risk of all-cause mortality in advanced chronic kidney disease and hemodialysis: the chronic renal insufficiency cohort study. Hypertension. 2015;65(1):93–100.
Hecking M, Moissl U, Genser B, et al. Greater fluid overload and lower interdialytic weight gain are independently associated with mortality in a large international hemodialysis population. Nephrol Dial Transplant. 2018;33(10):1832–42.
Agarwal R, Peixoto AJ, Santos SF, Zoccali C. Pre- and Postdialysis blood pressures are imprecise estimates of Interdialytic ambulatory blood pressure. Clin J Am Soc Nephrol. 2006;1(3):389–98.
Agarwal R, Andersen MJ, Bishu K, Saha C. Home blood pressure monitoring improves the diagnosis of hypertension in hemodialysis patients. Kidney Int. 2006;69(5):900–6.
Agarwal R, Brim NJ, Mahenthiran J, Andersen MJ, Saha C. Out-of-hemodialysis-unit blood pressure is a superior determinant of left ventricular hypertrophy. Hypertension. 2006;47(1):62–8.
Wang AY, Brimble KS, Brunier G, et al. ISPD cardiovascular and metabolic guidelines in adult peritoneal dialysis patients part II – Management of various cardiovascular complications. Perit Dial Int. 2015;35(4):388–96.
O’shaughnessy MM, Durcan M, Kinsella SM, Griffin MD, Reddan DN, Lappin DW. Blood pressure measurement in peritoneal dialysis: which method is best? Perit Dial Int. 2013;33(5):544–51.
Wang MC, Tseng CC, Tsai WC, Huang JJ. Blood pressure and left ventricular hypertrophy in patients on different peritoneal dialysis regimens. Perit Dial Int. 2001;21(1):36–42.
Vaios V, Georgianos PI, Vareta G, et al. Clinic and home blood pressure monitoring for the detection of ambulatory hypertension among patients on peritoneal dialysis. Hypertension. 2019;74(4):998–1004.
Sinha AD, Agarwal R. Can chronic volume overload be recognized and prevented in hemodialysis patients? The pitfalls of the clinical examination in assessing volume status. Semin Dial. 2009;22(5):480–2.
Agarwal R, Alborzi P, Satyan S, Light RP. Dry-weight reduction in hypertensive hemodialysis patients (Drip): a randomized, controlled trial. Hypertension. 2009;53(3):500–7.
Agarwal R, Andersen MJ, Pratt JH. On the importance of pedal edema in hemodialysis patients. Clin J Am Soc Nephrol. 2008;3(1):153–8.
Van Biesen W, Williams JD, Covic AC, et al. Fluid status in peritoneal dialysis patients: the European Body Composition Monitoring (EuroBCM) study cohort. PLoS One. 2011;6(2):E17148.
Ronco C, Verger C, Crepaldi C, et al. Baseline hydration status in incident peritoneal dialysis patients: the initiative of patient outcomes in dialysis (IPOD-PD study)dagger. Nephrol Dial Transplant. 2015;30(5):849–58.
Mallamaci F, Benedetto FA, Tripepi R, et al. Detection of pulmonary congestion by chest ultrasound in dialysis patients. JACC Cardiovasc Imaging. 2010;3(6):586–94.
Oh KH, Baek SH, Joo KW, et al. Does routine bioimpedance-guided fluid management provide additional benefit to non-anuric peritoneal dialysis patients? Results from COMPASS Clinical Trial. Perit Dial Int. 2018;38(2):131–8.
Tan BK, Yu Z, Fang W, et al. Longitudinal bioimpedance vector plots add little value to fluid management of peritoneal dialysis patients. Kidney Int. 2016;89(2):487–97.
Covic A, Ciumanghel AI, Siriopol D, et al. Value of bioimpedance analysis estimated “Dry Weight” in maintenance dialysis patients: a systematic review and meta-analysis. Int Urol Nephrol. 2017;49(12):2231–45.
Kim YL, Biesen WV. Fluid overload in peritoneal dialysis patients. Semin Nephrol. 2017;37(1):43–53.
Gunal AI, Duman S, Ozkahya M, et al. Strict volume control normalizes hypertension in peritoneal dialysis patients. Am J Kidney Dis. 2001;37(3):588–93.
Bargman JM, Thorpe KE, Churchill DN. Relative contribution of residual renal function and peritoneal clearance to adequacy of dialysis: a reanalysis of the Canusa Study. J Am Soc Nephrol. 2001;12(10):2158–62.
Medcalf JF, Harris KP, Walls J. Role of diuretics in the preservation of residual renal function in patients on continuous ambulatory peritoneal dialysis. Kidney Int. 2001;59(3):1128–33.
Tonbul Z, Altintepe L, Sozlu C, Yeksan M, Yildiz A, Turk S. The association of peritoneal transport properties with 24-hour blood pressure levels in CAPD patients. Perit Dial Int. 2003;23(1):46–52.
Htay H, Johnson DW, Wiggins KJ, et al. Biocompatible dialysis fluids for peritoneal dialysis. Cochrane Database Syst Rev. 2018;10:Cd007554.
Woodrow G, Oldroyd B, Stables G, Gibson J, Turney JH, Brownjohn AM. Effects of icodextrin in automated peritoneal dialysis on blood pressure and bioelectrical impedance analysis. Nephrol Dial Transplant. 2000;15(6):862–6.
Davies SJ, Woodrow G, Donovan K, et al. Icodextrin improves the fluid status of peritoneal dialysis patients: results of a double-blind randomized controlled trial. J Am Soc Nephrol. 2003;14(9):2338–44.
Paniagua R, Orihuela O, Ventura MD, et al. Echocardiographic, electrocardiographic and blood pressure changes induced by icodextrin solution in diabetic patients on peritoneal dialysis. Kidney Int Suppl. 2008;108:S125–30.
Davies S, Carlsson O, Simonsen O, et al. The effects of low-sodium peritoneal dialysis fluids on blood pressure, thirst and volume status. Nephrol Dial Transplant. 2009;24(5):1609–17.
Rutkowski B, Tam P, Van Der Sande FM, et al. Low-sodium versus standard-sodium peritoneal dialysis solution in hypertensive patients: a randomized controlled trial. Am J Kidney Dis. 2016;67(5):753–61.
Dombros N, Dratwa M, Feriani M et al. European Best Practice Guidelines for Peritoneal Dialysis. 7 Adequacy of peritoneal dialysis. Nephrol Dial Transplant. 2005;20(Suppl 9):Ix24–Ix27.
Agarwal R, Sinha AD. Cardiovascular protection with antihypertensive drugs in dialysis patients: systematic review and meta-analysis. Hypertension. 2009;53(5):860–6.
Heerspink HJ, Ninomiya T, Zoungas S, et al. Effect of lowering blood pressure on cardiovascular events and mortality in patients on dialysis: a systematic review and meta-analysis of randomised controlled trials. Lancet. 2009;373(9668):1009–15.
Shen JI, Saxena AB, Montez-Rath ME, Chang TI, Winkelmayer WC. Angiotensin-converting enzyme inhibitor/angiotensin receptor blocker use and cardiovascular outcomes in patients initiating peritoneal dialysis. Nephrol Dial Transplant. 2017;32(5):862–9.
Shigenaga A, Tamura K, Dejima T, et al. Effects of angiotensin ii type 1 receptor blocker on blood pressure variability and cardiovascular remodeling in hypertensive patients on chronic peritoneal dialysis. Nephron Clin Pract. 2009;112(1):C31–40.
Suzuki H, Nakamoto H, Okada H, Sugahara S, Kanno Y. A selective angiotensin receptor antagonist, valsartan, produced regression of left ventricular hypertrophy associated with a reduction of arterial stiffness. Adv Perit Dial. 2003;19:59–66.
Zhang L, Zeng X, Fu P, Wu HM. Angiotensin-Converting enzyme inhibitors and angiotensin receptor blockers for preserving residual kidney function in peritoneal dialysis patients. Cochrane Database Syst Rev. 2014;(6):Cd009120.
Agarwal R, Sinha AD, Pappas MK, Abraham TN, Tegegne GG. Hypertension in hemodialysis patients treated with atenolol or Lisinopril: a randomized controlled trial. Nephrol Dial Transplant. 2014;29(3):672–81.
Acknowledgments
Financial support: R.A. is supported by NIH 5 R01 HL126903 and a grant from VA Merit Review 1-I01CX001753.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 Springer Nature Switzerland AG
About this entry
Cite this entry
Georgianos, P.I., Agarwal, R. (2023). Blood Pressure Control in Peritoneal Dialysis. In: Khanna, R., Krediet, R.T. (eds) Nolph and Gokal's Textbook of Peritoneal Dialysis. Springer, Cham. https://doi.org/10.1007/978-3-030-62087-5_34
Download citation
DOI: https://doi.org/10.1007/978-3-030-62087-5_34
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-62086-8
Online ISBN: 978-3-030-62087-5
eBook Packages: MedicineReference Module Medicine